Medical Condition News

RSS

Researchers transform skin cells directly into oligodendrocyte precursor cells

Researchers at the Stanford University School of Medicine have succeeded in transforming skin cells directly into oligodendrocyte precursor cells, the cells that wrap nerve cells in the insulating myelin sheaths that help nerve signals propagate.

16 Apr 2013

UK's first TEDMEDLive Bristol event to be held at MShed

Could the quantum computing revolution transform drug development, are there new approaches for improving sleep and do people benefit from being diagnosed with early-stage dementia? These are some of the questions that will be discussed at the UK's first TEDMEDLive Bristol event at the MShed on Thursday [18 April].

16 Apr 2013

ACAAI to offer free screenings for allergies and asthma

More than 50 million Americans suffer from allergies and asthma, a number that continues to rise annually. To help children and adults with symptoms of these conditions know if they are at risk, allergists from around the country will conduct the 17th annual Nationwide Asthma Screening Program.

16 Apr 2013

White House mental health fix for security clearance process draws critics' questions

The Obama Administration is trying to revamp how the government approaches mental health issues in the security clearance process - but security and mental health experts say the proposed fix may open the door to new problems.

16 Apr 2013

New study examines weight loss benefits offered through health insurance

Although most overweight adults agree that health insurance benefits designed to promote weight loss are a good idea, they don't want to pay extra for them, finds a new study in the American Journal of Preventive Medicine.

16 Apr 2013

Study to examine ways to improve involvement of mental health service users

A groundbreaking study could help to revolutionise the way in which mental health service users and their carers plan their care.

16 Apr 2013

Study on targeted liver cancer therapy called SIR-Spheres microspheres completes patient recruitment

Australian-based global oncology company, Sirtex Medical Limited (ASX: SRX), has announced the completion of patient recruitment for its global SIRFLOX clinical study which is aimed at expanding the clinical use of its SIR-spheres® microspheres targeted radiation therapy from a last line medical treatment to a standard first-line oncology therapy.

16 Apr 2013

Junk DNA plays important role in brain development

Specific DNA once dismissed as junk plays an important role in brain development and might be involved in several devastating neurological diseases, UC San Francisco scientists have found.

16 Apr 2013

GTx to continue two pivotal Phase III clinical trials of enobosarm

GTx, Inc. today announced that a per protocol safety review of unblinded safety data on Friday April 12, 2013, by an independent Data Safety Monitoring Board, resulted in a determination that GTx continue as planned its two pivotal Phase III clinical trials of enobosarm (GTx-024) for the prevention and treatment of muscle wasting in patients with advanced non-small cell lung cancer.

16 Apr 2013

Aetna releases two new metabolic syndrome programs to lower risk factors

Aetna (NYSE: AET) today announced the launch of "Metabolic Health in Small Bytes" and the "Metabolic Health Advisor." The two new components can help people control the risk factors associated with metabolic syndrome.

16 Apr 2013

Acorda Therapeutics reports positive data from dalfampridine-ER post-stroke deficits trial

Acorda Therapeutics, Inc. today announced that a proof-of-concept trial found dalfampridine extended release tablets, marketed as AMPYRA (dalfampridine) Extended Release Tablets, 10 mg, improved walking in people with post-stroke deficits.

16 Apr 2013

Abbott recalls FreeStyle InsuLinx Blood Glucose Meters

Abbott today announced it is initiating a voluntary recall of FreeStyle InsuLinx Blood Glucose Meters in the United States.

16 Apr 2013

NeuroDerm enrolls patients for Phase IIa clinical trial of ND0612

NeuroDerm, Ltd. announced today that enrollment of patients is ongoing in its Phase IIa clinical trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease.

16 Apr 2013

MD Anderson researcher awarded 2013 Fight Colorectal Cancer-AACR Fellowship

For her research focusing on the refinement of predictive biomarkers and improving outcomes in the field of metastatic colorectal cancer, Maria Pia Morelli, M.D., Ph.D., has been awarded the 2013 Fight Colorectal Cancer-AACR Fellowship, in memory of Lisa Dubow.

16 Apr 2013

GWCI launches e-learning series to raise awareness of ongoing health care needs of cancer survivors

In collaboration with the American Cancer Society and the Centers for Disease Control and Prevention, the George Washington University Cancer Institute is launching the Cancer Survivorship E-Learning Series for Primary Care Providers on April 15, 2013.

16 Apr 2013

Michigan's first cardio-oncology clinic launched to prevent heart problems

As cancer therapy becomes more effective and the number of cancer survivors increases, doctors are faced with a new challenge: ensuring patients have a healthy heart to enjoy the rest of their lives.

16 Apr 2013

Implant improves vision for patients suffering from macular degeneration

Physicians at the Virginia Commonwealth University Medical Center have become the first in Virginia to successfully implant a telescope in a patient's eye to treat macular degeneration.

16 Apr 2013

Study: p38α MAPK protein functions as important switch to drive inflammatory responses in brain

Even a mild injury to the brain can have long lasting consequences, including increased risk of cognitive impairment later in life. While it is not yet known how brain injury increases risk for dementia, there are indications that chronic, long-lasting, inflammation in the brain may be important.

16 Apr 2013

Mental exercise may help prevent cognitive decline in healthy older adults

Cognitive training exercises - or mental exercise - may help prevent cognitive decline in healthy older adults, while evidence for the benefits of pharmacologic substances and exercise is weak, outlines a review published in CMAJ.

16 Apr 2013

Protein helps leukemia cells avoid effects of chemotherapy by appearing dormant

A new study on how the progression of acute lymphocytic leukemia is influenced by the bone marrow environment has demonstrated for the first time that targeting a specialized protein known as osteopontin may be an effective strategy to increase the efficacy of chemotherapy in patients with this type of blood cancer.

16 Apr 2013